NASDAQ:AMRX | News — Page 2 | Amneal Pharmaceuticals, Inc.

AMRX News — Page 2

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2018-05-07Current reportSEC filingAmneal Pharmaceuticals, Inc. filed Form 8-KAmneal Pharmaceuticals, Inc. filed Form 8-K covering items 2.02,9.01.
2018-05-07Current reportSEC filingAmneal Pharmaceuticals, Inc. filed Form 8-KAmneal Pharmaceuticals, Inc. filed Form 8-K covering items 1.01,1.02,2.01,3.02,4.01,5.01,5.02,5.03,9.01.